Clinical Trial Update: Evaluation of Boostrix™10 Years After Previous Booster Vaccination [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Boostrix 10 years after previous booster vaccination; completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acellular Pertussis
• Diphtheria
• Tetanus

Drugs mentioned

• Boostrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acellular Pertussis, Tetanus | Phase 4 | Status: COMPLETED | Results posted: 2013-10-08